Keyphrases
Alpha Subunit
37%
AN-7
21%
Angiogenesis
28%
Angiogenic
29%
Antiangiogenic Activity
17%
Anticancer Activity
14%
Antiphospholipid Antibodies
16%
Bleeding
22%
Chronic Myeloid Leukemia
15%
Coagulation Factor XIII
14%
Coagulation Factors
18%
Diethyl Phosphite
14%
Disease-causing mutations
15%
Endothelial Cells
31%
Factor V Leiden
23%
Factor XIII Deficiency
21%
Factor XIII Subunit A
15%
Factor XIIIa
35%
Fibrin
16%
Fibrinogen
18%
FXIII
68%
Histone Deacetylase Inhibitor (HDACi)
21%
Live Birth Rate
16%
Methylenetetrahydrofolate Reductase (MTHFR)
27%
Missense mutation
21%
Mitochondrial Myopathy
17%
Monocytes
17%
Oncology Patients
14%
Platelet Adhesion
28%
Platelet Aggregation
20%
Platelets
61%
Polymorphism
36%
Pregnancy Loss
33%
Protein Disulfide Isomerase
14%
Recombinant
20%
Recombinant Factor XIII
23%
Recombinant Fragment
21%
Recombinant FXIII
19%
Recurrent Miscarriage
30%
Recurrent Pregnancy Loss
25%
Ristocetin
14%
Sideroblastic Anemia
21%
Subunit Deficiency
15%
Thrombin
19%
Thrombophilia
31%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
16%
Von Willebrand Disease
84%
Von Willebrand Factor
100%
Von Willebrand Factor Concentrate
14%
Young Males
17%
Biochemistry, Genetics and Molecular Biology
Allele
24%
Alpha Chain
7%
Angiogenesis
28%
Anticancer
7%
Antiphospholipid Antibody
24%
Antithrombin
11%
Blood Coagulation Factor
21%
Blood Plasma
31%
Case-Control Study
8%
Cell Membrane
14%
Cross-Link
8%
Doxorubicin
14%
Exon
15%
Factor V
14%
Factor V Leiden
20%
Factor XIII
69%
Factor XIII Deficiency
15%
Fibrin Clot
8%
Fibrinogen
31%
Glycoprotein Ib
8%
Histone Deacetylase
14%
Homozygosity
9%
Kinase Insert Domain Receptor
11%
Leporidae
8%
Linkage Analysis
11%
Messenger RNA
14%
Methylenetetrahydrofolate Reductase
26%
Missense Mutation
12%
Mitochondrial Myopathy
14%
Molecular Weight
10%
Platelet
42%
Prevalence
40%
Protein C
21%
Protein Disulfide-Isomerase
7%
Protein S
9%
Prothrombinase
14%
Restriction Fragment Length Polymorphism
7%
Ristocetin
12%
Secretion (Process)
8%
Thrombin
19%
Thrombocyte Adhesion
26%
Thrombocyte Aggregation
19%
Thrombophilia
27%
Thrombospondin 1
7%
Tissue Plasminogen Activator
9%
Tissue Repair
13%
Vascular Endothelial Growth Factor
9%
Von Willebrand Disease
44%
Von Willebrand Factor
49%
Wound Healing
15%
Medicine and Dentistry
Adverse Event
11%
Antiangiogenic Activity
8%
Antineoplastic Activity
14%
Antiphospholipid Antibody
16%
Antithrombin
8%
Birth Rate
16%
Bleeding
19%
Bleeding Disorder
11%
Blood Clotting Factor
27%
Busulfan
7%
Chronic Myelogenous Leukemia
15%
Diarrhea
7%
Diseases
18%
Disseminated Intravascular Coagulation
7%
Endothelial Cell
23%
Factor V Leiden
17%
Factor VII
9%
Factor XIII
32%
Fibrin Clot
8%
Fibrinogen
11%
Glanzmann's Thrombasthenia
10%
High Output Cardiac Failure
7%
Histone Deacetylase Inhibitor
14%
Infarction
10%
Infection
14%
Lupus Anticoagulant
8%
Membrane Microparticle
7%
Messenger RNA
7%
Methylenetetrahydrofolate Reductase
12%
Microparticle
7%
Myelodysplastic Syndrome
14%
Myeloproliferative Disorder
7%
Neoplasm
10%
Non-Hodgkin Lymphoma
10%
Phlebothrombosis
8%
Platelet
47%
Prevalence
32%
Protein C
13%
Protein S
7%
Protein S Deficiency
9%
Prothrombin
10%
Recurrent Miscarriage
31%
Recurrent Pregnancy Loss
26%
Spontaneous Abortion
9%
Thrombophilia
34%
Thromboprophylaxis
14%
Thrombosis
13%
Von Willebrand Disease
28%
Von Willebrand Factor
21%
Wound Healing
11%